PHILLIP A SHARP
CIK 1226295 · last filed 2025-01-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$153.20M
Companies
4
Total Filings
68
Lifetime Open-Market Net
-$60.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALNY | Director | 266,899 | $202.31 | $54.00M | -$48.96M | 40 | 2025-01-24 |
| VIR | Director | 165,618 | $8.86 | $1.47M | $0 | 7 | 2023-05-24 |
| Syros Pharmaceuticals, Inc. (SYRS) Delisted | Director | 18,667 | $0.00 | $7 | $0 | 9 | 2022-06-02 |
| BIIB | Director | 470,278 | $207.82 | $97.74M | -$11.40M | 8 | 2009-06-05 |
Recent Filings · Page 4 of 7
68 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-22 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2018-06-15 | Syros Pharmaceuticals, Inc. (SYRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-03-14 | ALNY | Mixed | — | -$1.91M | EDGAR |
| 2018-03-13 | ALNY | Mixed | — | -$1.53M | EDGAR |
| 2017-09-22 | Syros Pharmaceuticals, Inc. (SYRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-12 | Syros Pharmaceuticals, Inc. (SYRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-06 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2017-02-03 | ALNY | Mixed | — | -$212.9K | EDGAR |
| 2017-01-27 | ALNY | Mixed | — | -$98.4K | EDGAR |
| 2017-01-20 | ALNY | Mixed | — | -$328.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.